Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Rating)’s stock price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $6.53 and traded as low as $0.68. Bellerophon Therapeutics shares last traded at $0.71, with a volume of 297,101 shares. Analysts Set New Price Targets A number […]
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 347,000 shares, an increase of 44.3% from the May 15th total of 240,400 shares. Based on an average trading volume of 614,200 shares, the days-to-cover ratio is […]
Brookline Capital Management downgraded shares of Bellerophon Therapeutics (NASDAQ:BLPH – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Monday morning, PriceTargets.com reports. A number of other equities research analysts have also recently commented on BLPH. StockNews.com raised shares of Bellerophon Therapeutics from a sell rating […]